504
品生产质量管理指南的对比分析
*
孙程洁，成殷，俞佳宁（上海药品审评核查中心，上海201203）
摘要目的：为我国申请加入药品检查合作计划（PIC/S），建立与国际统一的检查标准，提出细胞治
疗产品GMP检查亟需关注的差异点。方法：对我国细胞治疗产品指南与PIC/S先进治疗产品GMP附录进
行整体梳理和对比分析，并就一些关键问题进行了讨论。结果：我国与PIC/SGMP附录原则及考虑要素
基本是一致的，但从法规体系、框架结构、适用范围、具体要求均有所区别。结论：分别从质量风险管
理、起始生物材料的检查、与国际检查标准的统一三个方面提出了对此类产品GMP检查的启示。
关键词：药品检查合作计划；先进治疗产品；药品生产质量管理规范；细胞治疗；药品检查
R95A1002-7777(2023)05-0504-09
中图分类号：文献标识码：文章编号：
doi:10.16153/j.1002-7777.2023.05.003
ComparativeAnalysisoftheGMPAppendixofPIC/SAdvancedTherapeutic
MedicinalProductsandManufactureQualityManagementGuidelinesof
ChinasCellTherapyProducts
*
SunChengjie,ChengYin,YuJianing(ShanghaiCenterforDrugEvaluationandInspection,Shanghai201203,
China)
AbstractObjective:ForChinatoapplyforjoiningthePharmaceuticalInspectionCo-operationScheme(PIC/S),
establishinternationallyuni?edinspectionstandards,andputforwardthedi?erencesthatneedurgentattentionin
GMPinspectionofcelltherapyproducts.Methods:TheoverallcombingandcomparativeanalysisofChinascell
therapyproductguidelinesandtheGMPappendixofPIC/Sadvancedtherapeuticmedicinalproductswerecarried
out,andsomekeyissueswerediscussed.Results:TheprinciplesandconsiderationsofChinaandPIC/SGMP
appendixarebasicallythesame,buttheyaredi?erentfromtheregulatorysystem,frameworkstructure,scopeof
application,andspeci?crequirements.Conclusion:TheenlightenmentforGMPinspectionofsuchproductsis
proposedfromthreeaspects:qualityriskmanagement,inspectionofstartingbiologicalmaterials,anduni?cation
withinternationalinspectionstandards.
Keywords:PharmaceuticalInspectionCo-operationScheme(PIC/S);AdvancedTherapyMedicinalProducts
(ATMP);GoodManufacturePractice(GMP);celltherapy;druginspection
作者简